Diagnostic aid for the scintigraphic visualization of malignant

Details Diagnostic aid for the scintigraphic visualization of malignant Diagnostic aid for the scintigraphic visualization of malignant

1987-06-25

1989-12-05

Maples, John S.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

424 9, 252625, 252645, A61K 4902, C09K 1104

Patent

active

048851515

ABSTRACT:
A diagnostic aid for the scintigraphic visualization of malignant tumors which contains a radionuclide which is bonded by means of a complex-forming agent to the substance obtained by the enzymatic processing of murein with enzyme consisting essentially of hen's eggwhite lysozyme.

REFERENCES:
patent: 4364920 (1982-12-01), Winchell
patent: 4590060 (1986-05-01), Ehrenfeld
patent: 4596769 (1986-06-01), Shockman et al.
Weidel et al., Avd. & Enzymol., 26, 193-232 (1964).
Schumichen et al., Nucl. Med., 25, pp. 28-30, (1986).
Primosigh et al., Chem. Abst., Aug. 1961, No. 16674f-16674g.
Keenan, A. et al., "Monoclonal Antibodies in Nuclear Medicine", J. Nucl. Med., vol. 26, No. 5, pp. 531-537, 1985.
Glauner, B. et al., "The Analysis of Murein Composition With High-Pressure-Liquid Chromatography", The Target of Penicillin, Berlin, pp. 30-34, 1983.

Affiliated with

Also associated with

Rating

Diagnostic aid for the scintigraphic visualization of malignant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic aid for the scintigraphic visualization of malignant , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic aid for the scintigraphic visualization of malignant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2033396